AH-7921 (Doxylam) is an opioid analgesic drug selective for the μ-opioid receptor, having around 90% the potency of morphine when administered orally. [2] [3] [4] It was discovered in the 1970s [5] by a team at Allen and Hanburys located in the United Kingdom. [6]

AH-7921 is a structurally unique synthetic opioid analgesic that has recently entered the drug arena in Europe, the USA, and Japan. Although it was synthesized and patented in the mid-1970s, it was first identified in a seized sample purchased via ...

AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) is a new synthetic opioid and has led to multiple non-fatal and fatal intoxications. To comprehensively study AH-7921 metabolism, we assessed human liver microsome (HLM) metabolic ...

The AH-7921, a benzamide compound belonging to the U-compounds, developed by Allen and Hanburys Ltd. in the mid-1970s, has been very active in this group. Before the postulation of generic legislation by China for fentanyl-related substances in 2019 , the synthetic opioids sometimes appeared as the combination of FA and U-compounds .

AH 7921 (Item No. 12036) is an analytical reference material categorized as an opioid. 1 It is an analgesic with high addictive liability in animal models. 2,3 AH 7921 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.

AH-7921 is a central nervous system depressant. In addition to analgesia, relaxation, euphoria, so-called opiate glow, and alertness, occasional itching, nausea and tremors have been described by self-reporting users. Various analytically confirmed non-fatal and fatal intoxications involving AH-7921 have been reported in the literature.

Oct 10, 2014 · Since 2012, a new synthetic opioid named AH-7921 has become available within the recreational drug market 1. AH-7921, IUPAC name 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide, is an N-substituted cyclohexylmethylbenzamide where the benzamide moiety is dichlorinated at positions 3 and 4 of the ring and the …

It establishes a mechanism for the rapid exchange of information on new psychoactive substances and provides for an assessment of the risks associated with them in order to permit the measures applicable in the Member States for the control of narcotic and psychotropic substances to be applied also to new psychoactive substances.

AH-7921 is a structurally unique synthetic opioid analgesic that has recently entered the drug arena in Europe, the USA, and Japan. Although it was synthesized and patented in the mid-1970s, it was first identified in a seized sample purchased via the Internet in July 2012 and formally brought to th …

AH-7921 is a new, structurally atypical synthetic opioid analgesic that appears to be sold as a ‘‘research chemical’’ or ‘‘legal opioid’’ on the Internet since 2012.